Bozkurt, Hüseyin S.Quigley, Eamonn M. M.2024-07-122024-07-1220200394-63202058-738410.1177/20587384209613042-s2.0-85094633206https://doi.org/10.1177/2058738420961304https://hdl.handle.net/20.500.12415/7481COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a 'cytokine storm'. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects. These bacteria have the potential to ameliorate the 'cytokine storm' through a differential effect on pro- and anti-inflammatory cytokines. In the management of COVID-19 and other coronovirus-mediated illnesses, probiotic bacteria also have the potential to enhance vaccine efficacy.eninfo:eu-repo/semantics/openAccessBifidobacteriumCovid-19ProbioticEditorial33103512Q234WOS:000588306200001Q2